Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Development of a quantum dot based assay for the detection of cancer biomarkers

FY 2009-10

Summary
Cancer is one of the leading causes of death worldwide. Early detection of the disease helps to improve patient survival. This research focuses on developing highly sensitive assays for early detection of cancers. A novel approach of this project is to use a particular type of nanoparticle that can bind to a cancer cell and its specific protein molecule. Cancer cells can produce tumor markers, which may be found in bodily fluids. When the nanoparticle is added to a blood or saliva sample, it will produce a fluorescent signal if tumor markers are present. The use of nanoparticles to diagnose disease has the potential for the early detection of cancer, and can minimize invasive testing. By detecting cancer early, the health of the patient can be improved.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
200370
Name
Wagner Megan K
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Development of a quantum dot based assay for the detection of cancer biomarkers
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Assay For Tumor Markers; Cancer Diagnosis; Fluorescence Detection; Quantum Dot Nanoparticles
Abstract
Cancer is one of the leading causes of death worldwide. Early detection of the disease helps to improve patient survival. This research focuses on developing highly sensitive assays for early detection of cancers. A novel approach of this project is to use a particular type of nanoparticle that can bind to a cancer cell and its specific protein molecule. Cancer cells can produce tumor markers, which may be found in bodily fluids. When the nanoparticle is added to a blood or saliva sample, it will produce a fluorescent signal if tumor markers are present. The use of nanoparticles to diagnose disease has the potential for the early detection of cancer, and can minimize invasive testing. By detecting cancer early, the health of the patient can be improved.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Wagner, Megan K
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~